Nav: Home

Two months left to register for The International Liver CongressTM 2017

February 14, 2017

With just over two months to go until The International Liver Congress™ (ILC) 2017, it's time to register for your seat! The 52nd Annual Congress of The European Association for the Study of the Liver (EASL), is being held from 19-23 April, at the RAI Congress Centre, Amsterdam, The Netherlands. Ground-breaking data will be presented at three official press conferences, there will be an on-site press centre and private rooms available for conducting interviews with key speakers and EASL Governing Board members.

Don't miss the chance to attend the biggest hepatology event in Europe - media registration is open and free of charge, so e-mail the ILC Press Office now to obtain your personalised press registration code and register online today! Please ensure you are able to provide a valid press card or formal journalist credentials.

The International Liver CongressTM is a multi-disciplinary scientific event which attracts over 10,000 delegates from around the world every year. Our aim is to showcase the latest advances in hepatology and unveil a wide variety of new, innovative data to improve the management of liver disease.

The ILC Press Office Team is available to answer any questions you may have and can be contacted at: ILCpressoffice@ruderfinn.co.uk. Further information on media registration can be found here: http://ilc-congress.eu/media-registration/.

We look forward to welcoming you in Amsterdam!
-end-


European Association for the Study of the Liver

Related Liver Articles:

The liver increases by half during the day
In mammals, the liver reaches its maximum efficiency when they are active and feed.
The IT-LIVER European consortium unveils new TGF-beta functions in liver cancer
Recent research results from the European consortium IT-Liver provide a better understanding of the role of the TGF-beta cytokine in liver cancer.
New approach to liver transplantation: Using a damaged liver to replace a dying liver
There's new hope for patients with liver disease who are waiting for a donor liver to become available for transplantation.
Unlocking a liver receptor puzzle
The nuclear receptor LRH-1 acts in the liver to regulate metabolism of fat and sugar and is a target for potential diabetes drugs.
Serious liver-related condition on the rise in the US
A new analysis reveals that cirrhosis and acute on chronic liver failure (ACLF, a deterioration of liver function in patients with cirrhosis that results in the failure of one or more organs) represent a substantial and increasing health and economic burden in the United States.
Damage to tiny liver protein function leads to heart disease, fatty liver
A UCF College of Medicine researcher has identified for the first time a tiny liver protein that when disrupted can lead to the nation's top killer -- cardiovascular disease -- as well as fatty liver disease, a precursor to cancer.
Targeted treatment for liver cancer under way
Researchers at the University of Eastern Finland and Eberhard Karls Universität Tübingen have discovered a new molecular mechanism that can be used to inhibit the growth of hepatocellular carcinoma, which is the most common liver cancer.
Transplanted liver cells protect against liver failure after massive hepatectomy surgery
Because liver failure often occurs after an extensive hepatectomy, researchers using animal models investigated safer ways to transplant liver cells post-extensive hepatectomy found that rather than transplanting cells into the liver portal vein, transplantation into an extra-hepatic site, such as the intra-mesentery, a fold of membranous tissue on the posterior wall of the abdominal cavity attached to the intestinal tract, can help protect against post-operative liver failure and aid in survival of the remaining liver.
Fatty liver disease is common
Researchers have characterized the prevalence and risk factors of fatty liver disease in patients who undergo liver transplantation.
Many diabetics don't know they have serious liver disease
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the Western world.

Related Liver Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Jumpstarting Creativity
Our greatest breakthroughs and triumphs have one thing in common: creativity. But how do you ignite it? And how do you rekindle it? This hour, TED speakers explore ideas on jumpstarting creativity. Guests include economist Tim Harford, producer Helen Marriage, artificial intelligence researcher Steve Engels, and behavioral scientist Marily Oppezzo.
Now Playing: Science for the People

#524 The Human Network
What does a network of humans look like and how does it work? How does information spread? How do decisions and opinions spread? What gets distorted as it moves through the network and why? This week we dig into the ins and outs of human networks with Matthew Jackson, Professor of Economics at Stanford University and author of the book "The Human Network: How Your Social Position Determines Your Power, Beliefs, and Behaviours".